-
Fourth mRNA COVID-19 vaccination in immunocompromised patients with haematological malignancies (COBRA KAI): a cohort study
COBRA KAI Study Team, 1 Jul 2023, In: EClinicalMedicine. 61, 102040.Research output: Contribution to journal › Article › Academic › peer-review
-
Profiling the Fungal Microbiome after Fecal Microbiota Transplantation for Graft-versus-Host Disease: Insights from a Phase 1 Interventional Study
van Lier, Y. F., Rolling, T., Armijo, G. K., Zhai, B., Haverkate, N. J. E., Meijer, E., Nur, E., Blom, B., Peled, J. U., van den Brink, M. R. M., Hohl, T. M., Hazenberg, M. D. & Markey, K. A., Jan 2023, In: Transplantation and Cellular Therapy. 29, 1, p. 63.e1-63.e5Research output: Contribution to journal › Article › Academic › peer-review
-
Antibody Response in Immunocompromised Patients With Hematologic Cancers Who Received a 3-Dose mRNA-1273 Vaccination Schedule for COVID-19
COBRA KAI Study Team, 1 Oct 2022, In: JAMA Oncology. 8, 10, p. 1477-1483 7 p.Research output: Contribution to journal › Article › Academic › peer-review
- All publications